Delivery Order SPE2DB25D3020-SPE2DB25FWHSW
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $128,358.41 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-competitive award leveraging an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,686.48 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract, awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, utilizes firm fixed-price pricing and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,238.77 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery order. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,289.83 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed-price, competitively awarded contract is a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by July 25, 2025, and will be...
- The Defense Logistics Agency awarded a delivery order valued at $47,923.48 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors. The contract, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,028.84 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract issued to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award leverages AmerisourceBergen's established capability to supply critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,696.88 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract, awarded on September 2, 2025, with a completion date of September 3, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor. The place of...
- The Defense Logistics Agency awarded a $29,802.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with performance in Conshohocken, Pennsylvania. The contract, issued on June 2, 2025, with completion targeted for June 3, 2025, represents a competitively awarded non-set-aside order executed through the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a $38,088.74 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with a completion date of June 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $28,295.33 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract, issued on May 8, 2025, with an ultimate completion date of May 9, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWHSWDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,154.68 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract, issued on May 27, 2025, with an ultimate completion date of May 28, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The award reflects the company's demonstrated capability to meet federal procurement requirements through open competition and its role as a key supplier within DLA's pharmaceutical distribution network for defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.2k | 5/27/25 |